Preliminary Evaluation of Safety and Efficacy by [14C] AC0010 Trail and Subsequent AC0010 Treatment

Clinical trial NCT03053219 · COMPLETED

Trial details

NCT number: NCT03053219
Sponsor: Hangzhou ACEA Pharmaceutical Research Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma，Non-Small-Cell Lung

Start date: 2016-11-01
Primary completion: 2018-07-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.